AbbVie Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ABBV New York 2830 www.abbvie.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbbVie Inc.

3 Giant Dividend Stocks to Buy to Shield Your Portfolio Now - Jul 2nd, 2025 5:30 pm
The Zacks Analyst Blog Highlights Alphabet, AbbVie and The Walt Disney - Jul 2nd, 2025 8:46 am
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term - Jul 2nd, 2025 7:40 am
Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth? - Jul 2nd, 2025 7:07 am
Will AbbVie's Acquisition Spree Aid Pipeline Growth? - Jul 2nd, 2025 6:46 am
Exploring 3 High Growth Tech Stocks In The US Market - Jul 2nd, 2025 5:38 am
Top Stock Reports for Alphabet, AbbVie & Walt Disney - Jul 1st, 2025 2:31 pm
ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B - Jul 1st, 2025 8:05 am
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)? - Jul 1st, 2025 4:20 am
Sector Update: Health Care Stocks Higher Late Afternoon - Jun 30th, 2025 1:56 pm
Sector Update: Health Care Stocks Advance Monday Afternoon - Jun 30th, 2025 11:49 am
Top Midday Stories: Hewlett Packard, Juniper Settle Antitrust Suit With DOJ; Home Depot Unit Acquires GMS for $5.5 Billion - Jun 30th, 2025 9:37 am
Stocks See Support as Signs of Trade Progress Boost Market Sentiment - Jun 30th, 2025 8:07 am
AbbVie Agrees to Acquire Capstan Therapeutics for $2.1 Billion - Jun 30th, 2025 6:57 am
AbbVie to buy Capstan for up to $2.1 billion in immunology push - Jun 30th, 2025 6:42 am
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology - Jun 30th, 2025 6:31 am
U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance - Jun 30th, 2025 6:25 am
AbbVie to buy CAR-T developer Capstan in deal worth up to $2.1B - Jun 30th, 2025 6:00 am
AbbVie to Host Second-Quarter 2025 Earnings Conference Call - Jun 30th, 2025 6:00 am
3 Dividend Stocks to Double Up on Right Now - Jun 29th, 2025 2:51 am